Significant Contract Modifications ($10M+) — June 21, 2026
The two contracts analyzed, totaling $3.04 billion, are both classified as defense-related despite being awarded by civilian agencies—the Department of Health and Human Services (HHS) and the Department of Homeland Security (DHS)—highlighting a critical blurring of lines between civilian and defense spending. The dominant signal is a $1.78B award to Leidos Biomedical Research Inc. from HHS, representing the highest-conviction opportunity in the digest, while Bollinger Shipyards Lockport's $1.26B DHS contract underscores a separate maritime security theme. Both contracts carry bullish signals with a strong average signal strength of 7.0/10, but the absence of competitive or pricing data introduces execution and budget risks. Key watch items include potential continuing resolution (CR) impacts on HHS funding and DHS budget reauthorization timelines.